2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 59.501 | 76.097 | 73.618 | 83.349 | 87.736 | 91.140 | 104.357 | 116.646 | 112.885 | 127.701 |
Total Income - EUR | 62.354 | 73.671 | 75.965 | 81.773 | 91.750 | 90.381 | 110.319 | 116.722 | 117.174 | 128.799 |
Total Expenses - EUR | 60.716 | 65.351 | 75.218 | 77.688 | 85.553 | 98.596 | 104.217 | 110.111 | 113.558 | 130.546 |
Gross Profit/Loss - EUR | 1.639 | 8.321 | 747 | 4.085 | 6.197 | -8.215 | 6.102 | 6.611 | 3.616 | -1.747 |
Net Profit/Loss - EUR | -158 | 6.991 | 9 | 3.243 | 5.310 | -9.131 | 5.422 | 5.785 | 2.722 | -2.771 |
Employees | 6 | 6 | 5 | 5 | 5 | 0 | 4 | 4 | 4 | 5 |
Check the financial reports for the company - Alfarm Ferestre Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 512 | 893 | 22.956 | 18.341 | 19.516 | 17.547 | 25.378 | 15.752 | 25.469 | 19.773 |
Current Assets | 13.064 | 15.557 | 11.650 | 15.486 | 20.891 | 10.368 | 13.540 | 21.947 | 19.699 | 43.888 |
Inventories | 7.899 | 7.487 | 10.520 | 9.365 | 15.200 | 8.514 | 6.662 | 15.864 | 15.106 | 36.076 |
Receivables | 0 | 0 | 789 | 2.118 | 387 | 0 | 2.501 | 1.834 | 3.389 | 3.271 |
Cash | 5.165 | 8.070 | 342 | 4.003 | 5.305 | 1.854 | 4.378 | 4.249 | 1.204 | 4.540 |
Shareholders Funds | -113 | 6.876 | 6.815 | 9.943 | 15.071 | 5.648 | 10.963 | 16.504 | 19.277 | 16.448 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 13.689 | 9.574 | 27.964 | 23.884 | 25.350 | 22.267 | 27.956 | 21.194 | 25.891 | 47.690 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "2512 - 2512" | |||||||||
CAEN Financial Year |
2512
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Alfarm Ferestre Srl